Harel Adrian 4
4 · BRAINSTORM CELL THERAPEUTICS INC · Filed Aug 16, 2011
Insider Transaction Report
Form 4
Harel Adrian
Acting Chief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2011-08-10+70,000→ 70,000 totalExercise: $0.20Exp: 2021-08-10→ Common Stock (70,000 underlying)
Footnotes (1)
- [F1]Option vests and becomes exercisable as to 100% of the number of shares subject to the option upon the earlier of (i) the Issuer's receipt of clean room approval, or (ii) the Issuer's treatment of its first six patients, provided that reporting person remains an employee of Issuer on such date.